Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 45, 2021 - Issue 6
Submit an article Journal homepage
252
Views
9
CrossRef citations to date
0
Altmetric
Review Article

Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis

Sezaneh Haghpanaha Hematology Research Center, Shiraz, University of Medical Sciences, Shiraz, IranORCID Iconhttps://orcid.org/0000-0002-8666-2106View further author information
ORCID Icon,
Mahnaz Hosseini-Bensenjana Hematology Research Center, Shiraz, University of Medical Sciences, Shiraz, IranView further author information
,
Mehrab Sayadib Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, IranView further author information
&
Mehran Karimia Hematology Research Center, Shiraz, University of Medical Sciences, Shiraz, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8555-1001View further author information
ORCID Icon
Pages 371-379 | Received 28 Mar 2021, Accepted 21 Apr 2021, Published online: 24 May 2021

References

  • Zafari M, Rad MTS, Mohseni F, et al. β-Thalassemia major and coronavirus-19, mortality and morbidity: a systematic review study. Hemoglobin. 2021;45(1):1–4. Epub 2020 Dec 14.
  • Fisler G, Izard SM, Shah S, et al. Characteristics and risk factors associated with critical illness in pediatric COVID-19. Ann Intensive Care. 2020;10(1):171.
  • Karimi M, Haghpanah S, Azarkeivan A, et al. Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: a nationwide Iranian experience. Mediterr J Hematol Infect Dis. 2021;13(1):e2021008.
  • Fathi M, Vakili K, Sayehmiri F, et al. The prognostic value of comorbidity for the severity of COVID-19: a systematic review and meta-analysis study. PLoS One. 2021;16(2):e0246190. eCollection 2021.
  • de Sanctis V, Canatan D, Vives CJ, et al. Preliminary data on COVID-19 in patients with hemoglobinopathies: a multicentre ICET-A study. Mediterr J Hematol Infect Dis. 2020;12(1):e2020046.
  • Karimi M, Haghpanah S, Zarei T, et al. Prevalence and severity of coronavirus disease 2019 (COVID-19) in transfusion dependent and non-transfusion dependent β-thalassemia patients and effects of associated comorbidities: an Iranian nationwide study. Acta Biomed. 2020;91(3):e2020007.
  • Kehinde TA, Osundiji MA. Sickle cell trait and the potential risk of severe coronavirus disease 2019-A mini-review. Eur J Haematol. 2020;105(5):519–523.
  • Minniti CP, Zaidi AU, Nouraie M, et al. Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection. Blood Adv. 2021;5(1):207–215.
  • Ramachandran P, Perisetti A, Kathirvelu B, et al. Low morbidity and mortality with COVID 19 in sickle cell disease: a single center experience. EJHaem. 2020;1(2):608–614.
  • Saliba AN, Atoui A, Labban M, et al. Thalassemia in the emergency department: special considerations for a rare disease. Ann Hematol. 2020;99(9):1967–1977.
  • Sivalingam T, Inusa B, Doyle P, et al. COVID-19 and the pulmonary complications of sickle cell disease. EJHaem. 2020;1(2):545–547.
  • Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Munn Z, Moola S, Riitano D, et al. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123–128.
  • Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Motta I, De Amicis MM, Pinto VM, et al. SARS-CoV-2 infection in beta thalassemia: preliminary data from the Italian experience. Am J Hematol. 2020;95(8):E198–E199.
  • Telfer P, De la Fuente J, Sohal M, et al. Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients. Haematologica. 2020;105(11):2651–2654.
  • Arlet J-B, de Luna G, Khimoud D, et al. Prognosis of patients with sickle cell disease and COVID-19: a French experience. Lancet Haematol. 2020;7(9):e632–e634.
  • AbdulRahman A, AlAli S, Yaghi O, et al. COVID-19 and sickle cell disease in Bahrain. Int J Infect Dis. 2020;101:14–16.
  • Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020. Emerg Infect Dis. 2020;26(10):2473–2476.
  • McCloskey KA, Meenan J, Hall R, et al. COVID-19 infection and sickle cell disease: a UK centre experience. Br J Haematol. 2020;190(2):e57–e58.
  • World Health Organization. Coronavirus disease (COVID-19) Situation Report (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.).
  • worldometers. Population-by-country. (https://www.worldometers.info/world-population/population-by-country/.)
  • Chowdhury SF, Anwar S. Management of hemoglobin disorders during the COVID-19 pandemic. Front Med (Lausanne)). 2020;7:306.
  • Noun P, Ibrahim A, Hodroj MH, et al. COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals. Expert Rev Hematol. 2020;13(10):1081–1092.
  • Drouin E. Beta-thalassemia may protect against COVID 19. Med Hypotheses. 2020;143:110014.
  • Lansiaux E, Pébaÿ PP, Picard JL, Son-Forget J. COVID-19: beta-thalassemia subjects immunised? Med Hypotheses. 2020;142:109827.
  • Florez-Perdomo WA, Serrato-Vargas SA, Bosque-Varela P, et al. Relationship between the history of cerebrovascular disease and mortality in COVID-19 patients: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;197:106183.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.